Ashish M. Kamat is Professor of Urologic Oncology and Cancer Research at UT MD Anderson Cancer Center; Associate Cancer Center Director, RFHNH in Mumbai, and President of International Bladder Cancer Group (IBCG). He is Associate Editor for European Urology Oncology, directed the MDACC Urologic Oncology Fellowship from 2005-2016, and a graduate of the AUA Leadership Program. Dr Kamat’s focus is on bladder cancer, immunotherapy and organ sparing therapies. His laboratory studies predictive markers of response to therapy, and mechanisms of inducible cancer stem cells. Dr Kamat has over 275 publications, is listed in ‘Who’s Who in Medicine’ and ‘Best Doctors in America’, and has won the ‘Compassionate Doctor Award’ from patient groups.